S. Günay, “Risk factors for the development of interstitial lung disease following severe COVID-19 pneumonia and outcomes of systemic corticosteroid therapy: 3-month follow-up: Interstitial lung disease following severe COVID-19 pneumonia”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 40, no. 3, p. e2023029, Sep. 2023, doi: 10.36141/svdld.v40i3.14418.